ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$RPRX:NASDAQ · ROYALTY PHARMA PLC

Sector: health

Conviction from: NASDAQ

52-week range: 37.3170.37

Royalty Pharma acquires royalty interests in approved and development-stage prescription drugs, funding biopharmaceutical innovation in exchange for future royalty streams.

4 tracked filer(s) hold this · 0 opened, 2 added, 2 trimmed in 30-SEP-2026

Aggregate 13FScore 71 — mean of 4 scored holder(s) · buyers (new/add) avg 65. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275Added +954%1,123,256$65,553,2200.1%
Bridgewater55Added +116%474,521$27,693,0460.1%
Pat Dorsey / Dorsey Asset94Trimmed -2%2,415,667$140,978,3268.2%
Paul Tudor Jones / Tudor61Trimmed -16%510,736$29,806,5530.0%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

FiledFormActivist% of classConviction
2026-02-20SCHEDULE 13D/ASevergnini Achille G.5.7%Medfiling

Trump & executive branch trades all Trump/exec trades →

2 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-07-01Trump, Donald J PresidentSELL$1,001 - $15,000PTR
2026-05-14Trump, Donald J PresidentBUY$1,001 - $15,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.